KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $127,000 | -20.1% | 12,796 | +2.3% | 0.02% | -41.0% |
| Q1 2015 | $159,000 | -34.3% | 12,503 | -26.9% | 0.04% | -50.0% |
| Q4 2014 | $242,000 | -68.7% | 17,108 | -69.5% | 0.08% | -26.4% |
| Q3 2014 | $772,000 | +108.6% | 56,181 | +133.4% | 0.11% | +82.8% |
| Q2 2014 | $370,000 | – | 24,073 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |